NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis

BioFactors

Volumn 25, Issue 1-4, 2005, Pages 43-60

  De Luca, Thomas ^a   Morré, Dorothy M ^a   Zhao, Haiyun ^b   Morré, D James ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

( ) epigallocatechin 3 gallate (EGCg); Apoptosis; Cancer; Capsaicin; Ceramide; Coenzyme Q; ECTO NOX; NADH oxidase; Plasma membrane electron transport; Sphingomyelinase; Sphingosine kinase; Sphingosine 1 phosphate; tNOX

Indexed keywords

CERAMIDE; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; UBIDECARENONE; UBIQUINONE;

APOPTOSIS; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME INACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; STEADY STATE;

EID: 33746068256     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520250106     Document Type: Conference Paper

References (61)

1. 1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1, Cancer Research 65 (2005), 3364-3373.
2. M.P. Barroso-Maré, C. Gomez-Diaz, J.M. Villalba, M.I. Buron, G. Lopez-Lluch and P. Navas, Plasma membrane ubiquinone controls ceramide production and prevents cell death induced by serum withdrawal, Journal of Bioenergetics and Biomembranes 29 (1997), 259-267.
3. K. Bernardo, O. Krut, K. Wiegmann, D. Kreder, M. Micheli, R. Schafer, A. Sickman, W.E. Schmidt, J.M. Schroder, H.E. Meyer, K. Sandhoff and M. Kronke, Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain, Journal of Biological Chemistry 275 (2000), 7641-7647.
4. R. Bose, M. Verheij, A. Haimovitz-Friedman, K. Scotto, Z. Fuks and R. Kolesnick, Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signal, Cell 82 (1995), 405-414.
5. P.-J. Chueh, D.M. Morré, C. Penel, T. DeHahn and D.J. Morré, The hormone-responsive NADH oxidase of the plant plasma membrane has properties of a NADH: protein disulfide reductase, Journal of Biological Chemistry 272 (1997), 11221-11227.
6. P.-J. Chueh, C. Kim, N. Cho, D.M. Morré and D.J. Morré, Molecular cloning and characterization of a tumor-associated, growth-related and time-keeping hydroquinone (NADH) oxidase (NOX) of the HeLa cell surface, Biochemistry 41 (2002), 3732-3741.
7. P.-J. Chueh, L.-Y. Wu, D.M. Morré and D.J. Morré, tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin gallate, BioFactors 20 (2004), 249-263.
8. M.G. Cifone, P. Roncaioli, R. De Maria, G. Camarda, A. Santoni, G. Ruberti and R. Testi, Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal, EMBO Journal 14 (1995), 5859-5868.
9. E. Gulbins and H. Grassmé, Ceramide and cell death receptor clustering. Biochimica et Biophysica Acta 1585 (2002), 139-145.
10. E. Gulbins, K.M. Coggeshall, B. Brenner, K. Schlottmann, O. Linderkamp and F. Lang, Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway, Journal of Biological Chemistry 271 (1996), 26389-26394.
11. A. Haimovitz-Friedman, C.C. Kan, D. Ehleiter, R.S. Persaud, M. McLoughlin, Z. Fuks and R.N. Kolesnick, Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis, Journal of Expermential Medicine 180 (1994), 525-535.
12. Y.A. Hannun, The sphingomyelin cycle and the second messenger function of ceramide, Journal of Biological Chemistry 269 (1994), 3125-3128.
13. A. Jana and K. Pahan, Fibrillar amyloid-β peptides kill human primary neurons via nadph oxidase-mediated activation of neutral sphingomyelinase: implications for Alzheimer's disease. Journal of Biological Chemistry 279 (2004), 51451-51459.
14. J. Kamsteeg, T. Rutherford, E. Sapi, B. Hanczaruk, S. Shahhabi, M. Flick, D. Brown and G. Mor, Phenoxodiol - an isoflavones analog - induces apoptosis in chemoresistant ovarian cancer cells, Oncogene 22 (2003), 2611-2620.
15. G. Kelly, Interim results of a phase Ib/IIa study of oral phenoxodiol in patients with late-stage, hormone-refractory prostate cancer (abstract), Proceedings of the American Association of Cancer Research 45(Suppl. 1) (2004), 103-104.
16. W.H. Kim, K.C. Ghil, J.H. Lee, S.H. Yeo, Y.J. Chun, K.H. Choi, D.K. Kim and M.Y. Kim, Involvement of p27 (kip1) in ceramide-mediated apoptosis in HL-60 cells, Cancer Letters 151 (2000), 39-48.
17. T. Kishi, D.M. Morré and D.J. Morré, The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity, Biochimia et Biophysica Acta 1412 (1999), 66-77.
18. S.F. Kralik, X. Du, C. Patel and J.P. Walsh, A method for quantitative extraction of sphingosine 1-phosphate into organic solvent, Analytical Biochemistry 294 (2001), 190-193.
19. M. Lauricella, M. Giuliano, S. Emmanuele, M. Carabillo, R. Vento and G. Tesoriere, Increased cyclin E. level in retinoblastoma cells during programmed cell death, Cellular Molecular Biology 44 (1998), 1229-1235.
20. C. Leblanc, C. Boyen, O. Richard, G. Bonnard, J.M. Grienenberger and B. Kloareg, Complete sequence of the mitochondrial DNA of the rhodophyte Chondrus crispus (Gigartinales). Gene content and genome organization, Journal of Molecular Biology 250 (1995), 484-495.
21. X. Li, X. Ding and T.E. Adrian. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GAPDH expression, Pancreas 27 (2003), 174-179.
22. B. Liu and Y.A. Hannun, Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione, Journal of Biological Chemistry 272 (1997), 16281-16287.
23. B. Lliu, N. Andrieu-Abadie, T. Levade, P. Zhang, L.M. Obeid and Y.A. Hannun, Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death, Journal of Biological Chemistry 273 (1998), 11313-11320.
24. B. Liu, D.F. Hassler, G.K. Smith, K. Weaver and Y.A. Hannun, Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain, Journal of Biological Chemistry 273 (1998), 34472-34479.
25. M. Maceyka, S.G. Payne, S. Milstien and S. Spiegel, Sphingosine kinase, sphingosine-1-phosphate, and apoptosis, Biochimica et Biophysica Acta 1585 (2002), 193-201.
26. V. Mansat, G. Laurent, T. Levade, A. Bettaieb and J.P. Jaffrezou, The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin, Cancer Research 57 (1997), 5300-5304.
27. N. Marchesini and Y.A. Hannun, Acid and neutral sphingomyelinases: roles and mechanisms of regulation, Biochemistry and Cell Biology 82 (2004), 27-44.
28. N. Marchesini, C. Luberto and Y.A. Hannun, Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism, Journal of Biological Chemistry (2003), 13775-13783.
29. + dependent sphingomyelinase by ubiquinol-mediated plasma membrane electron transport, Protoplasma 221 (2003), 109-116.
30. J. Min, A.L. Stegner, H. Alexander and S. Alexander, Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs, Eukaryotic Cell 3 (2004), 795-805.
31. D.J. Morré, NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-4-\(4-methylphenylsulfonyl)-N-(4- chlorophenyl)urea (LY181984) at an external site, Biochimica et Biophysica Acta 1240 (1997), 201-208.
32. D.J. Morré, NADH oxidase: A multifunctional ectoprotein of the eukaryotic cell surface, in: Plasma Membrane Redox Systems and their Role in Biological Stress and Disease, H. Asard, A. Bérczi and R. Caubergs, eds, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1998, pp. 121-156.
33. D.J. Morré and D.M. Morré, Mammalian plasma membranes by aqueous tow-phase partition, Biotechniques 7 (1989), 946-958.
34. D.M. Morré and D.J. Morré, Mechanism of killing of HeLa cells by the antitumor sulfonylurea N-4(-methylphenylsulfonyl)-N′-(4- chlorophenyl)urea (LY181984). Protoplasma 184 (1995), 188-195.
35. D.J. Morré and D.M. Morré, Cell surface NADH oxidase (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases, Free Radical Research 37 (2003), 759-808.
36. D.J. Morré and T. Reust, A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4(-methylphenylsulfonyl)- N′-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients, Journal of Bioenergetics and Biomembranes 29 (1997), 281-289.
37. D.J. Morré, P.-J. Chueh and D.M. Morré, Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture, Proceedings of National Academy of Science USA 92 (1995), 1821-1835.
38. D.J. Morré, L.-Y. Wu and D.M. Morré, The antitumor sulfonylurea N-4(-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membrane, Biochimica et Biophysica Acta 1240 (1995), 11-17.
39. D.J. Morré, F.E. Wilkinson, C. Kim, N. Cho, J. Lawrence, D.M. Morré and D. McClure, Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media, Biochimica et Biophysica Acta 1280 (1996), 197-206.
40. D.J. Morré, S. Caldwell, A. Mayorga, L.-Y. Wu and D.M. Morré, NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients, Archives of Biochemistry and Biophysics 342 (1997), 224-230.
41. D.J. Morré, C. Kim, M. Paulik, D.M. Morré and W.P. Faulk, Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin? Journal of Bioenergetics and Biomembranes 29 (1997), 269-280.
42. D.J. Morré, P.-J. Chueh, J. Lawler and D.M. Morré, The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity, Journal of Bioenergetics and Biomembranes 30 (1998), 477-487.
43. D.J. Morré, A. Bridge, L.-Y. Wu and D.M. Morré, Epigallocatechin gallate inhibits preferentially the NADH oxidase and growth of transformed cells in culture, Biochemical Pharmacology 60 (2000), 937-946.
44. P. Navas, D.M. Fernandez-Ayala, S.F. Martin, G. Lopez-Lluch, R. De Cabo, J.C. Rodriguez-Aguilera and J.M. Villalba, Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells, Free Radical Research 36 (2002), 369-374.
45. +/NAD(P)H, Molecular and Cellular Biochemistry 273 (2005), 161-167.
46. D.J. Panka, T. Mano, T. Suhara, K. Walsh and J.W. Mier, Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. Journal of Biological Chemistry 276 (2001), 6893-6896.
47. L.E. Quintern and K. Sandhoff, Human acid sphingomyelinase from human urine, Methods in Enzymology 197 (1991), 536-540.
48. N.S. Radin, Killing tumors by ceramide-induced apoptosis. Critical available drugs, Biochemical Journal 371 (2003), 243-256.
49. B.G. Rao and M.W. Spence, Spingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0, Journal of Lipid Research 17 (1976), 506-515.
50. P.P. Ruvolo, Intracellular signal transduction pathways activated by ceramide and its metabolites, Pharmacology Research 47 (2003), 383-392.
51. D. Sedlak, D.M. Morré and D.J. Morré, A drug-unresponsive and protease-resistant CNOX protein from human sera, Archives of Biochemistry and Biophysics 386 (2001), 106-116.
52. I. Singh, K. Pahan, M. Khan and A.K. Singh, Cytokine-mediated induction of ceramide production is redox-sensitive, Implications to proinflammatory cytokine-mediated apoptosis in demyelinating disease, Journal of Biological Chemistry 273 (1998), 20354-20362.
53. S. Spiegel, O. Cuvillier, L.C. Edsall, T. Kohama, R. Menzeleev, Z. Olah, A. Olivera, G. Pinanov, D.M. Thomas, Z. Tu, J.R. Van Brocklyn and F. Wang, Sphingosine-1-phosphate in cell growth and cell death, Annals of New York Academy of Science 845 (1998), 11-18.
54. I. Spyridopoulos, P. Mayer, K.S. Shook, D.L. Axel, R. Viebahn and K.R. Karsch, Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human artial endothelial cells, Cardiovascular Research 50 (2001), 97-107.
55. T. Suhara, T. Mano, B.E. Oliveira and K. Walsh, Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP), Circulation Research 89 (2001), 13-19.
56. X. Tang, Z. Tian, P.-J. Chueh, S. Chen, D.M. Morré and D.J. Morré, Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface. In preparation.
57. V.P. Walter, T.M. Kloppel, I.G. Deumling and D.J. Morré, Alterations in neutral glycosphingolipids from transplantable hepatomas and in sera of rats bearing transplantable hepatomas, Cancer of Biochemistry and Biophysics 4 (1980), 145-151.
58. E. Wilkinson, Phenoxodiol offers hope for ovarian cancer, Lancet Oncology 5 (2004), 201.
59. ras immunoprecipitates of rat liver plasma membranes by agents affecting redox state, Biochemistry and Biophysics Research Communications 190 (1993), 229-235.
60. Y. Zhang, B. Yo, S. Delikat, S. Bayumy, X.H. Lin, S. Basu, M. McGinley, P.Y. Chan-Hui, H. Lichenstein and R. Kolesnick, Kinase suppressor of Ras is ceramide-activated protein kinase, Journal of Biological Chemistry 273 (1998), 30419-30426.
61. X. Zhu, Z.C. Liu, B.F. Xie, G.K. Feng and Y.X. Zeng, Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells, Cancer Letters 193 (2003), 149-154.